Global Fluorescence in situ hybridization probe Market

Fluorescence in situ hybridization probe Comprehensive Study by Type (RNA, DNA), Application (Cancer Diagnosis, Genetic Disorders, Others), End-User (Research Institutes, Diagnostic Centre, Biotechnology Companies, Companion Diagnostics, Academic Institutes), Technique (Q- FISH, Flow- FISH) Players and Region - Global Market Outlook to 2027

Fluorescence in situ hybridization probe Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Fluorescence in situ hybridization probe Market Scope?
It is a laboratory technique that is used for detecting a particular or a specific DNA or RNA sequence in the chromosome. The technique depends on exposing chromosomes to a tiny low DNA sequence known as a quest that encompasses a fluorescent module. It is one of the methods for localizing a piece of DNA within a genome that is called the Fluorescence in situ hybridization probe. The fluorescent dye is attached to a purified piece of DNA and then the DNA is incubated with a full set of chromosomes. The DNA is labeled which finds its matching pair in one of the chromosomes and sticks by it. By looking under the microscope the researcher can find the region where the DNA is bound because of the dye which is fluorescently attached to it.

The Fluorescence in situ hybridization probe market study is being classified by Type (RNA and DNA), by Application (Cancer Diagnosis, Genetic Disorders and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Fluorescence in situ hybridization probe market throughout the predicted period.

Abbott Laboratories (United States), Abnova Corporation (Taiwan), Agilent Technologies (United States), Biocare Medical, LLC (United States), Biosearch Technologies Inc. (United States), F. Hoffmann-La Roche AG (Switzerland), Genemed Biotechnologies (United States), Life Science Technologies (India), Oxford Gene Technologies (United Kingdom) and PerkinElmer Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Horizon Diagnostics (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Fluorescence in situ hybridization probe market by Type, Application and Region.

On the basis of geography, the market of Fluorescence in situ hybridization probe has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In January 2019, Oxford Gene Technology announced that it had received the US FDA's “de novo classification” for eight of its “Cytocell Aquarius Hematology Fluorescent In Situ Hybridization Probes (FISH)” that are specifically for acute myeloid Leukemia (AML) and myelodysplastic syndromes (AML) have developed MDS) applications. This leads to greater consumer acceptance of their products as the probes deliver high-quality results in less time. and In April 2018, Agilent Technologies, Inc. announced that it had added several offerings to its In-Situ Hybridization Probes that are compatible with its Dako Omnis product. They also announced that a manual IGFISH panel for use in lymphoma that is already CE-marked for in vitro diagnostics will be available to the European market. Using these probes in combination with Agilent's “Dako Omnis” improves results efficiency and increases the productivity of research laboratories.


Influencing Market Trend
  • Growing Adaption of the In-Vitro Diagnosis
  • Adoption of Advanced Technologies

Market Drivers
  • Growing Prevalence of Genetic Disorders
  • Increase in the Number of Chronic Disease Occurrence
  • Rising Prevalence of Breast Cancer

Opportunities
  • Government Initiatives to Support the R & D

Restraints
  • High Cost of the Technique
  • Existence of Variations in The Regulations for The Development and Usage of These Probes

Challenges
  • Absence of The Skilled Professionals to Interact and Utilize the Technology


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Fluorescence in situ hybridization probe, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • RNA
  • DNA
By Application
  • Cancer Diagnosis
  • Genetic Disorders
  • Others
By End-User
  • Research Institutes
  • Diagnostic Centre
  • Biotechnology Companies
  • Companion Diagnostics
  • Academic Institutes

By Technique
  • Q- FISH
  • Flow- FISH

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Genetic Disorders
      • 3.2.2. Increase in the Number of Chronic Disease Occurrence
      • 3.2.3. Rising Prevalence of Breast Cancer
    • 3.3. Market Challenges
      • 3.3.1. Absence of The Skilled Professionals to Interact and Utilize the Technology
    • 3.4. Market Trends
      • 3.4.1. Growing Adaption of the In-Vitro Diagnosis
      • 3.4.2. Adoption of Advanced Technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fluorescence in situ hybridization probe, by Type, Application, End-User, Technique and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Fluorescence in situ hybridization probe (Value)
      • 5.2.1. Global Fluorescence in situ hybridization probe by: Type (Value)
        • 5.2.1.1. RNA
        • 5.2.1.2. DNA
      • 5.2.2. Global Fluorescence in situ hybridization probe by: Application (Value)
        • 5.2.2.1. Cancer Diagnosis
        • 5.2.2.2. Genetic Disorders
        • 5.2.2.3. Others
      • 5.2.3. Global Fluorescence in situ hybridization probe by: End-User (Value)
        • 5.2.3.1. Research Institutes
        • 5.2.3.2. Diagnostic Centre
        • 5.2.3.3. Biotechnology Companies
        • 5.2.3.4. Companion Diagnostics
        • 5.2.3.5. Academic Institutes
      • 5.2.4. Global Fluorescence in situ hybridization probe by: Technique (Value)
        • 5.2.4.1. Q- FISH
        • 5.2.4.2. Flow- FISH
      • 5.2.5. Global Fluorescence in situ hybridization probe Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Fluorescence in situ hybridization probe (Price)
      • 5.3.1. Global Fluorescence in situ hybridization probe by: Type (Price)
  • 6. Fluorescence in situ hybridization probe: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abnova Corporation (Taiwan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Agilent Technologies (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Biocare Medical, LLC (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biosearch Technologies Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Genemed Biotechnologies (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Life Science Technologies (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Oxford Gene Technologies (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PerkinElmer Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Fluorescence in situ hybridization probe Sale, by Type, Application, End-User, Technique and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Fluorescence in situ hybridization probe (Value)
      • 7.2.1. Global Fluorescence in situ hybridization probe by: Type (Value)
        • 7.2.1.1. RNA
        • 7.2.1.2. DNA
      • 7.2.2. Global Fluorescence in situ hybridization probe by: Application (Value)
        • 7.2.2.1. Cancer Diagnosis
        • 7.2.2.2. Genetic Disorders
        • 7.2.2.3. Others
      • 7.2.3. Global Fluorescence in situ hybridization probe by: End-User (Value)
        • 7.2.3.1. Research Institutes
        • 7.2.3.2. Diagnostic Centre
        • 7.2.3.3. Biotechnology Companies
        • 7.2.3.4. Companion Diagnostics
        • 7.2.3.5. Academic Institutes
      • 7.2.4. Global Fluorescence in situ hybridization probe by: Technique (Value)
        • 7.2.4.1. Q- FISH
        • 7.2.4.2. Flow- FISH
      • 7.2.5. Global Fluorescence in situ hybridization probe Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Fluorescence in situ hybridization probe (Price)
      • 7.3.1. Global Fluorescence in situ hybridization probe by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fluorescence in situ hybridization probe: by Type(USD Million)
  • Table 2. Fluorescence in situ hybridization probe RNA , by Region USD Million (2016-2021)
  • Table 3. Fluorescence in situ hybridization probe DNA , by Region USD Million (2016-2021)
  • Table 4. Fluorescence in situ hybridization probe: by Application(USD Million)
  • Table 5. Fluorescence in situ hybridization probe Cancer Diagnosis , by Region USD Million (2016-2021)
  • Table 6. Fluorescence in situ hybridization probe Genetic Disorders , by Region USD Million (2016-2021)
  • Table 7. Fluorescence in situ hybridization probe Others , by Region USD Million (2016-2021)
  • Table 8. Fluorescence in situ hybridization probe: by End-User(USD Million)
  • Table 9. Fluorescence in situ hybridization probe Research Institutes , by Region USD Million (2016-2021)
  • Table 10. Fluorescence in situ hybridization probe Diagnostic Centre , by Region USD Million (2016-2021)
  • Table 11. Fluorescence in situ hybridization probe Biotechnology Companies , by Region USD Million (2016-2021)
  • Table 12. Fluorescence in situ hybridization probe Companion Diagnostics , by Region USD Million (2016-2021)
  • Table 13. Fluorescence in situ hybridization probe Academic Institutes , by Region USD Million (2016-2021)
  • Table 14. Fluorescence in situ hybridization probe: by Technique(USD Million)
  • Table 15. Fluorescence in situ hybridization probe Q- FISH , by Region USD Million (2016-2021)
  • Table 16. Fluorescence in situ hybridization probe Flow- FISH , by Region USD Million (2016-2021)
  • Table 17. South America Fluorescence in situ hybridization probe, by Country USD Million (2016-2021)
  • Table 18. South America Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 19. South America Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 20. South America Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 21. South America Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 22. Brazil Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 23. Brazil Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 24. Brazil Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 25. Brazil Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 26. Argentina Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 27. Argentina Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 28. Argentina Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 29. Argentina Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 30. Rest of South America Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 31. Rest of South America Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 32. Rest of South America Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 33. Rest of South America Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 34. Asia Pacific Fluorescence in situ hybridization probe, by Country USD Million (2016-2021)
  • Table 35. Asia Pacific Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 36. Asia Pacific Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 37. Asia Pacific Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 38. Asia Pacific Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 39. China Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 40. China Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 41. China Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 42. China Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 43. Japan Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 44. Japan Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 45. Japan Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 46. Japan Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 47. India Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 48. India Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 49. India Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 50. India Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 51. South Korea Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 52. South Korea Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 53. South Korea Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 54. South Korea Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 55. Australia Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 56. Australia Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 57. Australia Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 58. Australia Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 59. Rest of Asia-Pacific Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 60. Rest of Asia-Pacific Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 61. Rest of Asia-Pacific Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 63. Europe Fluorescence in situ hybridization probe, by Country USD Million (2016-2021)
  • Table 64. Europe Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 65. Europe Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 66. Europe Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 67. Europe Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 68. Germany Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 69. Germany Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 70. Germany Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 71. Germany Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 72. France Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 73. France Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 74. France Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 75. France Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 76. Italy Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 77. Italy Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 78. Italy Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 79. Italy Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 80. United Kingdom Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 81. United Kingdom Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 82. United Kingdom Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 83. United Kingdom Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 84. Netherlands Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 85. Netherlands Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 86. Netherlands Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 87. Netherlands Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 88. Rest of Europe Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 89. Rest of Europe Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 90. Rest of Europe Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 91. Rest of Europe Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 92. MEA Fluorescence in situ hybridization probe, by Country USD Million (2016-2021)
  • Table 93. MEA Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 94. MEA Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 95. MEA Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 96. MEA Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 97. Middle East Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 98. Middle East Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 99. Middle East Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 100. Middle East Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 101. Africa Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 102. Africa Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 103. Africa Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 104. Africa Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 105. North America Fluorescence in situ hybridization probe, by Country USD Million (2016-2021)
  • Table 106. North America Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 107. North America Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 108. North America Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 109. North America Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 110. United States Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 111. United States Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 112. United States Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 113. United States Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 114. Canada Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 115. Canada Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 116. Canada Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 117. Canada Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 118. Mexico Fluorescence in situ hybridization probe, by Type USD Million (2016-2021)
  • Table 119. Mexico Fluorescence in situ hybridization probe, by Application USD Million (2016-2021)
  • Table 120. Mexico Fluorescence in situ hybridization probe, by End-User USD Million (2016-2021)
  • Table 121. Mexico Fluorescence in situ hybridization probe, by Technique USD Million (2016-2021)
  • Table 122. Fluorescence in situ hybridization probe: by Type(USD/Units)
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Fluorescence in situ hybridization probe: by Type(USD Million)
  • Table 134. Fluorescence in situ hybridization probe RNA , by Region USD Million (2022-2027)
  • Table 135. Fluorescence in situ hybridization probe DNA , by Region USD Million (2022-2027)
  • Table 136. Fluorescence in situ hybridization probe: by Application(USD Million)
  • Table 137. Fluorescence in situ hybridization probe Cancer Diagnosis , by Region USD Million (2022-2027)
  • Table 138. Fluorescence in situ hybridization probe Genetic Disorders , by Region USD Million (2022-2027)
  • Table 139. Fluorescence in situ hybridization probe Others , by Region USD Million (2022-2027)
  • Table 140. Fluorescence in situ hybridization probe: by End-User(USD Million)
  • Table 141. Fluorescence in situ hybridization probe Research Institutes , by Region USD Million (2022-2027)
  • Table 142. Fluorescence in situ hybridization probe Diagnostic Centre , by Region USD Million (2022-2027)
  • Table 143. Fluorescence in situ hybridization probe Biotechnology Companies , by Region USD Million (2022-2027)
  • Table 144. Fluorescence in situ hybridization probe Companion Diagnostics , by Region USD Million (2022-2027)
  • Table 145. Fluorescence in situ hybridization probe Academic Institutes , by Region USD Million (2022-2027)
  • Table 146. Fluorescence in situ hybridization probe: by Technique(USD Million)
  • Table 147. Fluorescence in situ hybridization probe Q- FISH , by Region USD Million (2022-2027)
  • Table 148. Fluorescence in situ hybridization probe Flow- FISH , by Region USD Million (2022-2027)
  • Table 149. South America Fluorescence in situ hybridization probe, by Country USD Million (2022-2027)
  • Table 150. South America Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 151. South America Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 152. South America Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 153. South America Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 154. Brazil Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 155. Brazil Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 156. Brazil Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 157. Brazil Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 158. Argentina Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 159. Argentina Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 160. Argentina Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 161. Argentina Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 162. Rest of South America Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 163. Rest of South America Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 164. Rest of South America Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 165. Rest of South America Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 166. Asia Pacific Fluorescence in situ hybridization probe, by Country USD Million (2022-2027)
  • Table 167. Asia Pacific Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 168. Asia Pacific Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 169. Asia Pacific Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 170. Asia Pacific Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 171. China Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 172. China Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 173. China Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 174. China Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 175. Japan Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 176. Japan Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 177. Japan Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 178. Japan Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 179. India Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 180. India Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 181. India Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 182. India Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 183. South Korea Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 184. South Korea Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 185. South Korea Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 186. South Korea Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 187. Australia Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 188. Australia Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 189. Australia Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 190. Australia Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 191. Rest of Asia-Pacific Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 192. Rest of Asia-Pacific Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 193. Rest of Asia-Pacific Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 194. Rest of Asia-Pacific Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 195. Europe Fluorescence in situ hybridization probe, by Country USD Million (2022-2027)
  • Table 196. Europe Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 197. Europe Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 198. Europe Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 199. Europe Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 200. Germany Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 201. Germany Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 202. Germany Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 203. Germany Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 204. France Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 205. France Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 206. France Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 207. France Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 208. Italy Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 209. Italy Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 210. Italy Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 211. Italy Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 212. United Kingdom Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 213. United Kingdom Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 214. United Kingdom Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 215. United Kingdom Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 216. Netherlands Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 217. Netherlands Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 218. Netherlands Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 219. Netherlands Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 220. Rest of Europe Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 221. Rest of Europe Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 222. Rest of Europe Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 223. Rest of Europe Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 224. MEA Fluorescence in situ hybridization probe, by Country USD Million (2022-2027)
  • Table 225. MEA Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 226. MEA Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 227. MEA Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 228. MEA Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 229. Middle East Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 230. Middle East Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 231. Middle East Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 232. Middle East Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 233. Africa Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 234. Africa Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 235. Africa Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 236. Africa Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 237. North America Fluorescence in situ hybridization probe, by Country USD Million (2022-2027)
  • Table 238. North America Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 239. North America Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 240. North America Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 241. North America Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 242. United States Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 243. United States Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 244. United States Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 245. United States Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 246. Canada Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 247. Canada Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 248. Canada Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 249. Canada Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 250. Mexico Fluorescence in situ hybridization probe, by Type USD Million (2022-2027)
  • Table 251. Mexico Fluorescence in situ hybridization probe, by Application USD Million (2022-2027)
  • Table 252. Mexico Fluorescence in situ hybridization probe, by End-User USD Million (2022-2027)
  • Table 253. Mexico Fluorescence in situ hybridization probe, by Technique USD Million (2022-2027)
  • Table 254. Fluorescence in situ hybridization probe: by Type(USD/Units)
  • Table 255. Research Programs/Design for This Report
  • Table 256. Key Data Information from Secondary Sources
  • Table 257. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fluorescence in situ hybridization probe: by Type USD Million (2016-2021)
  • Figure 5. Global Fluorescence in situ hybridization probe: by Application USD Million (2016-2021)
  • Figure 6. Global Fluorescence in situ hybridization probe: by End-User USD Million (2016-2021)
  • Figure 7. Global Fluorescence in situ hybridization probe: by Technique USD Million (2016-2021)
  • Figure 8. South America Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 9. Asia Pacific Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 10. Europe Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 11. MEA Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 12. North America Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 13. Global Fluorescence in situ hybridization probe: by Type USD/Units (2016-2021)
  • Figure 14. Global Fluorescence in situ hybridization probe share by Players 2021 (%)
  • Figure 15. Global Fluorescence in situ hybridization probe share by Players (Top 3) 2021(%)
  • Figure 16. Global Fluorescence in situ hybridization probe share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 20. Abnova Corporation (Taiwan) Revenue, Net Income and Gross profit
  • Figure 21. Abnova Corporation (Taiwan) Revenue: by Geography 2021
  • Figure 22. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 23. Agilent Technologies (United States) Revenue: by Geography 2021
  • Figure 24. Biocare Medical, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 25. Biocare Medical, LLC (United States) Revenue: by Geography 2021
  • Figure 26. Biosearch Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Biosearch Technologies Inc. (United States) Revenue: by Geography 2021
  • Figure 28. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2021
  • Figure 30. Genemed Biotechnologies (United States) Revenue, Net Income and Gross profit
  • Figure 31. Genemed Biotechnologies (United States) Revenue: by Geography 2021
  • Figure 32. Life Science Technologies (India) Revenue, Net Income and Gross profit
  • Figure 33. Life Science Technologies (India) Revenue: by Geography 2021
  • Figure 34. Oxford Gene Technologies (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Oxford Gene Technologies (United Kingdom) Revenue: by Geography 2021
  • Figure 36. PerkinElmer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. PerkinElmer Inc. (United States) Revenue: by Geography 2021
  • Figure 38. Global Fluorescence in situ hybridization probe: by Type USD Million (2022-2027)
  • Figure 39. Global Fluorescence in situ hybridization probe: by Application USD Million (2022-2027)
  • Figure 40. Global Fluorescence in situ hybridization probe: by End-User USD Million (2022-2027)
  • Figure 41. Global Fluorescence in situ hybridization probe: by Technique USD Million (2022-2027)
  • Figure 42. South America Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 43. Asia Pacific Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 44. Europe Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 45. MEA Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 46. North America Fluorescence in situ hybridization probe Share (%), by Country
  • Figure 47. Global Fluorescence in situ hybridization probe: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Abnova Corporation (Taiwan)
  • Agilent Technologies (United States)
  • Biocare Medical, LLC (United States)
  • Biosearch Technologies Inc. (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Genemed Biotechnologies (United States)
  • Life Science Technologies (India)
  • Oxford Gene Technologies (United Kingdom)
  • PerkinElmer Inc. (United States)
Additional players considered in the study are as follows:
Horizon Diagnostics (United States)
Select User Access Type

Key Highlights of Report


Apr 2022 208 Pages 51 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Fluorescence in situ hybridization probe Market Quantitative research analysis
Global Fluorescence in situ hybridization probe Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Fluorescence in situ hybridization probe market is expected to see a growth of % during projected year 2021 to 2027.
The prominent players of Global Fluorescence in situ hybridization probe market are Abbott Laboratories (United States), Abnova Corporation (Taiwan), Agilent Technologies (United States), Biocare Medical, LLC (United States), Biosearch Technologies Inc. (United States), F. Hoffmann-La Roche AG (Switzerland), Genemed Biotechnologies (United States), Life Science Technologies (India), Oxford Gene Technologies (United Kingdom) and PerkinElmer Inc. (United States), to view complete player list click here

Know More About Global Fluorescence in situ hybridization probe Market Report?

Have a Query? Click Here

Other Related Reports

Artificial Blood Vessels Comprehensive Study by Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, Others), Application (Aortic Disease, Peripheral artery disease, Haemodialysis), End-User (...
$ 3650
Non Coding Rna Assays Comprehensive Study by Application (Oncological Applications, Biomarker Development, Infectious Medicine, Other Applications), End User (Research Laboratories, Biotechnology Aca...
$ 3350
Rodent Surgery Services Comprehensive Study by Type (Aseptic Technique, Survival Surgery, Major Survival Surgery, Multiple Survival Surgeries), Application (Hamsters, Gerbils, Guinea Pig, Mice, Rats)...
$ 3750
Video Microscope Comprehensive Study by Type (3D, 2D), Application (Academic Research Institute, Forensic and Pathology Laboratory, Other), Industry Verticals (Biopharmaceutical, Food and Beverage, M...
$ 3450
Glass Bioreactors Comprehensive Study by Application (Pharmaceutical, Biotechnology, Vaccine Development, Biological Research, Others), Components (Microbial Cultures, Cell Cultures, Batch, Others), ...
$ 3450
Flexible Biomanufacturing Platform Comprehensive Study by Type (Single-use Technology, Modular Environment, Advanced Process Automation, Standardization), Modality (Machine Flexibility, Material Hand...
$ 3350